Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Carballido J et al. - Effective treatment of benign prostatic hyperplasia (BPH) improves lower urinary tract symptoms (LUTS) and patient quality of life, and reduces the risk of complications arising from disease progression. An adjusted and multivariate analysis of the results of D-IMPACT will allow identification of the most efficient combination of tests that facilitate accurate BPH diagnosis in the primary care setting. In addition, D-IMPACT will estimate the prevalence of BPH in patients who present spontaneously to GPs with LUTS.


Today in Oncology...keeping you current

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09

Today in Voiding Dys/Incontinence...keeping you current

Alpha blockers prior to removal of a catheter for acute urinary retention in adult men
Cochrane Reviews, 10/19/09

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address